David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
CALL
Twilio
TWLO
$34.4B
| $19.2M | 0.02% |
148,500
+5,600
| +4% | +$631K |
|
727
Smith & Wesson
SWBI
$613M
| $19.2M | 0.02% |
2,670,116
-269,361
| -9% | -$2.44M |
|
|
UMPQ
728
DELISTED
Umpqua Holdings Corp
UMPQ
| $19.2M | 0.02% |
1,161,608
+267,360
| +30% | +$4.71M |
|
|
PPLI
729
CALL
People Inc
PPLI
$2.92B
| $19.2M | 0.02% |
510,301
-243,960
| -32% | -$9.03M |
|
730
PUT
Cummins
CMI
$78.9B
| $19.1M | 0.02% |
121,000
-79,700
| -40% | -$12M |
|
731
CALL
Costco
COST
$429B
| $19.1M | 0.02% |
78,800
-132,900
| -63% | -$29.1M |
|
732
iShares Core MSCI Emerging Markets ETF
IEMG
$160B
| $19M | 0.02% |
367,588
-64,575
| -15% | -$3.27M |
|
733
Upbound Group
UPBD
$1.11B
| $18.9M | 0.02% |
907,219
+30,477
| +3% | +$562K |
|
734
Ambev
ABEV
$44.4B
| $18.9M | 0.02% |
4,396,534
+2,915,529
| +197% | +$13.4M |
|
|
APC
735
PUT
DELISTED
Anadarko Petroleum
APC
| $18.9M | 0.02% |
415,300
+144,000
| +53% | +$6.53M |
|
736
Macy's
M
$5.97B
| $18.8M | 0.02% |
784,363
+735,445
| +1,503% | +$18.6M |
|
737
Burlington
BURL
$20.4B
| $18.8M | 0.02% |
120,121
-321,230
| -73% | -$51.8M |
|
738
Graphic Packaging
GPK
$3.35B
| $18.8M | 0.02% |
1,488,344
+1,224,884
| +465% | +$14.9M |
|
|
RDUS
739
DELISTED
Radius Health, Inc.
RDUS
| $18.8M | 0.02% |
941,650
+286,310
| +44% | +$5.22M |
|
740
Pultegroup
PHM
$24.5B
| $18.7M | 0.02% |
670,549
-16,067
| -2% | -$438K |
|
741
CALL
Occidental Petroleum
OXY
$58.9B
| $18.6M | 0.02% |
281,700
+75,100
| +36% | +$4.95M |
|
742
NETSCOUT
NTCT
$2.78B
| $18.6M | 0.02% |
663,188
+39,168
| +6% | +$1.04M |
|
|
TIF
743
DELISTED
Tiffany & Co.
TIF
| $18.6M | 0.02% |
176,293
-173,006
| -50% | -$15.9M |
|
|
BNFT
744
DELISTED
Benefitfocus, Inc.
BNFT
| $18.6M | 0.02% |
374,991
+109,553
| +41% | +$5.6M |
|
745
Expeditors International
EXPD
$24.4B
| $18.5M | 0.02% |
244,142
+82,494
| +51% | +$5.96M |
|
746
MKS Inc
MKSI
$18.5B
| $18.5M | 0.02% |
198,957
-273,777
| -58% | -$22.1M |
|
747
PUT
General Dynamics
GD
$102B
| $18.5M | 0.02% |
109,300
+27,600
| +34% | +$4.65M |
|
|
ELP
748
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $18.3M | 0.02% |
4,926,100
+368,210
| +8% | +$1.37M |
|
749
PUT
Lockheed Martin
LMT
$130B
| $18.3M | 0.02% |
60,800
+15,100
| +33% | +$4.43M |
|
750
Oshkosh
OSK
$9.67B
| $18.2M | 0.02% |
242,516
-12,484
| -5% | -$922K |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.